Medpace Holdings Inc.(MEDP)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

MEDP Medpace Holdings Inc.

休市中 05-09 16:00:00 EDT

296.03

-4.78

-1.59%

盘后296.03

+0.000.00%

18:37 EDT

最高302.86	最低295.92	成交量19.99万
今开301.79	昨收300.81	日振幅2.31%
总市值85.08亿	流通市值66.75亿	总股本2,874万
成交额5,955万	换手率0.89%	流通股本2,255万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"MEDP","market":"US","secType":"STK","nameCN":"Medpace Holdings Inc.","latestPrice":296.03,"timestamp":1746820800000,"preClose":300.81,"halted":0,"volume":199939,"hourTrading":{"tag":"盘后","latestPrice":296.03,"preClose":296.03,"latestTime":"18:37 EDT","volume":4060,"amount":1201983.81,"timestamp":1746830249653},"delay":0,"floatShares":22546783,"shares":28741609,"eps":13.089812,"marketStatus":"休市中","change":-4.78,"latestTime":"05-09 16:00:00 EDT","open":301.79,"high":302.855,"low":295.92,"amount":59550441.57395,"amplitude":0.023054,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":13.089812,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1747036800000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":1470888000000,"exchange":"NASDAQ","adjPreClose":300.81,"preHourTrading":{"tag":"盘前","latestPrice":300.81,"preClose":300.81,"latestTime":"08:02 EDT","volume":16,"amount":4802.49024,"timestamp":1746792171242},"postHourTrading":{"tag":"盘后","latestPrice":296.03,"preClose":296.03,"latestTime":"18:37 EDT","volume":4060,"amount":1201983.81,"timestamp":1746830249653},"volumeRatio":0.46080910112572004,"impliedVol":0.3606,"impliedVolPercentile":0.284},"requestUrl":"/m/hq/s/MEDP","defaultTab":"news","newsList":[{"id":"2534804614","title":"Medpace Holdings, Inc.跌0.39% 股价跌破300美元大关","url":"https://stock-news.laohu8.com/highlight/detail?id=2534804614","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2534804614?lang=zh_cn&edition=full","pubTime":"2025-05-09 21:45","pubTimestamp":1746798321,"startTime":"0","endTime":"0","summary":"北京时间2025年05月09日21时45分，Medpace Holdings, Inc.股票出现波动，股价大幅下跌0.39%。Medpace Holdings, Inc.股票所在的生命科学行业中，整体跌幅为0.22%。Medpace Holdings, Inc.公司简介：Medpace 是一家成立超过30年的晚期合同研究组织，为中小型生物技术、制药和医疗器械公司提供全方位的药物开发和临床试验服务。全球私募股权公司Cinven于2014年以9.15亿美元收购了Medpace，并于2018年退出了投资。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250509214521a478405a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250509214521a478405a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2065170008.USD","LU2065171402.SGD","MEDP","BK4121","LU2065169927.USD","LU2065171311.SGD","BK4585","BK4588"],"gpt_icon":0},{"id":"2533963056","title":"Medpace Holdings, Inc.涨3.94% 股价突破300美元大关","url":"https://stock-news.laohu8.com/highlight/detail?id=2533963056","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533963056?lang=zh_cn&edition=full","pubTime":"2025-05-08 03:43","pubTimestamp":1746647001,"startTime":"0","endTime":"0","summary":"北京时间2025年05月08日03时43分，Medpace Holdings, Inc.股票出现异动，股价急速上涨3.94%。Medpace Holdings, Inc.股票所在的生命科学行业中，整体涨幅为1.67%。Medpace Holdings, Inc.公司简介：Medpace 是一家成立超过30年的晚期合同研究组织，为中小型生物技术、制药和医疗器械公司提供全方位的药物开发和临床试验服务。全球私募股权公司Cinven于2014年以9.15亿美元收购了Medpace，并于2018年退出了投资。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050803432194ef8f63&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050803432194ef8f63&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2065171402.SGD","MEDP","BK4588","LU2065169927.USD","LU2065170008.USD","LU2065171311.SGD","BK4585","BK4121"],"gpt_icon":0},{"id":"2532008025","title":"Medpace Holdings, Inc.跌3.37% 股价跌破300美元大关","url":"https://stock-news.laohu8.com/highlight/detail?id=2532008025","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2532008025?lang=zh_cn&edition=full","pubTime":"2025-05-01 21:31","pubTimestamp":1746106295,"startTime":"0","endTime":"0","summary":"北京时间2025年05月01日21时31分，Medpace Holdings, Inc.股票出现异动，股价大幅跳水3.37%。Medpace Holdings, Inc.股票所在的生命科学行业中，整体涨幅为0.26%。Medpace Holdings, Inc.公司简介：Medpace 是一家成立超过30年的晚期合同研究组织，为中小型生物技术、制药和医疗器械公司提供全方位的药物开发和临床试验服务。全球私募股权公司Cinven于2014年以9.15亿美元收购了Medpace，并于2018年退出了投资。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250501213135a46ef1dc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250501213135a46ef1dc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","LU2065171311.SGD","LU2065170008.USD","BK4585","LU2065169927.USD","BK4121","MEDP","LU2065171402.SGD"],"gpt_icon":0},{"id":"2530874289","title":"Medpace Holdings, Inc.涨0.62% 股价突破300美元大关","url":"https://stock-news.laohu8.com/highlight/detail?id=2530874289","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530874289?lang=zh_cn&edition=full","pubTime":"2025-04-28 21:31","pubTimestamp":1745847084,"startTime":"0","endTime":"0","summary":"北京时间2025年04月28日21时31分，Medpace Holdings, Inc.股票出现波动，股价快速上涨0.62%。Medpace Holdings, Inc.股票所在的生命科学行业中，整体涨幅为0.68%。Medpace Holdings, Inc.公司简介：Medpace 是一家成立超过30年的晚期合同研究组织，为中小型生物技术、制药和医疗器械公司提供全方位的药物开发和临床试验服务。全球私募股权公司Cinven于2014年以9.15亿美元收购了Medpace，并于2018年退出了投资。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042821312494e5f15b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042821312494e5f15b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","LU2065170008.USD","LU2065171311.SGD","LU2065171402.SGD","BK4121","MEDP","BK4585","LU2065169927.USD"],"gpt_icon":0},{"id":"2530995268","title":"Medpace Holdings, Inc.涨3.29% 股价突破300美元大关","url":"https://stock-news.laohu8.com/highlight/detail?id=2530995268","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530995268?lang=zh_cn&edition=full","pubTime":"2025-04-25 00:08","pubTimestamp":1745510909,"startTime":"0","endTime":"0","summary":"北京时间2025年04月25日00时08分，Medpace Holdings, Inc.股票出现异动，股价快速拉升3.29%。Medpace Holdings, Inc.股票所在的生命科学行业中，整体涨幅为0.01%。Medpace Holdings, Inc.公司简介：Medpace 是一家成立超过30年的晚期合同研究组织，为中小型生物技术、制药和医疗器械公司提供全方位的药物开发和临床试验服务。全球私募股权公司Cinven于2014年以9.15亿美元收购了Medpace，并于2018年退出了投资。该信息摘要如下：Truist Securities：维持Medpace Hldgs评级，由持有调整至持有评级, 目标价由333.00美元调整至300.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042500082994e142e2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042500082994e142e2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2065171311.SGD","LU2065171402.SGD","BK4585","BK4121","MEDP","LU2065169927.USD","LU2065170008.USD","BK4588"],"gpt_icon":0},{"id":"1180529339","title":"异动解读 | 美德康控股(Medpace Holdings)股价盘中大涨5.12%，尽管分析师下调目标价","url":"https://stock-news.laohu8.com/highlight/detail?id=1180529339","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1180529339?lang=zh_cn&edition=full","pubTime":"2025-04-23 22:00","pubTimestamp":1745416821,"startTime":"0","endTime":"0","summary":"周三盘中，美德康控股股价大幅上涨5.12%，引起市场广泛关注。截至发稿时，该股报296.93美元。有趣的是，这一强劲涨势出现在多家华尔街分析机构下调其目标价之际。Leerink Partners将美德康控股的目标价从330美元下调至288美元，Mizuho将目标价从355美元下调至328美元，而Truist Securities则将目标价从333美元下调至300美元。尽管面临目标价下调，美德康控股股价的强劲表现表明，投资者可能正关注该公司的其他积极因素。","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"异动解读 | 美德康控股(Medpace Holdings)股价盘中大涨5.12%，尽管分析师下调目标价","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["MEDP"],"gpt_icon":0},{"id":"2529681669","title":"Medpace Holdings, Inc.盘中异动 急速上涨5.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2529681669","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529681669?lang=zh_cn&edition=full","pubTime":"2025-04-23 21:31","pubTimestamp":1745415102,"startTime":"0","endTime":"0","summary":"北京时间2025年04月23日21时31分，Medpace Holdings, Inc.股票出现波动，股价大幅上涨5.19%。Medpace Holdings, Inc.股票所在的生命科学行业中，整体涨幅为2.75%。Medpace Holdings, Inc.公司简介：Medpace 是一家成立超过30年的晚期合同研究组织，为中小型生物技术、制药和医疗器械公司提供全方位的药物开发和临床试验服务。全球私募股权公司Cinven于2014年以9.15亿美元收购了Medpace，并于2018年退出了投资。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250423213143aa2c7809&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250423213143aa2c7809&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2065170008.USD","LU2065171402.SGD","BK4585","MEDP","LU2065171311.SGD","LU2065169927.USD","BK4588","BK4121"],"gpt_icon":0},{"id":"1116019883","title":"异动解读 | Medpace盘中大跌13.24%，投行下调目标价引发市场担忧","url":"https://stock-news.laohu8.com/highlight/detail?id=1116019883","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1116019883?lang=zh_cn&edition=full","pubTime":"2025-04-22 21:36","pubTimestamp":1745328983,"startTime":"0","endTime":"0","summary":"临床研究外包服务提供商Medpace Holdings Inc.今日盘中股价大跌13.24%，延续了此前的下跌趋势，引发市场广泛关注。这一显著跌幅主要源于投资银行杰富瑞下调了公司的目标价，从300美元下调至285美元，反映了分析师对公司未来增长前景的担忧。值得注意的是，Medpace股价在此前的交易中已经出现大幅下跌。作为生物技术、制药和医疗器械行业的领先临床研究外包服务提供商，Medpace的股价波动也可能反映了市场对整个生物医药行业前景的担忧。","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["MEDP"],"gpt_icon":0},{"id":"2529845835","title":"Medpace Holdings, Inc.股价重挫11.10% 市值跌8.51亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2529845835","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529845835?lang=zh_cn&edition=full","pubTime":"2025-04-22 21:31","pubTimestamp":1745328671,"startTime":"0","endTime":"0","summary":"北京时间2025年04月22日21时31分，Medpace Holdings, Inc.股票出现波动，股价大幅下挫11.10%。Medpace Holdings, Inc.股票所在的生命科学行业中，整体涨幅为1.75%。Medpace Holdings, Inc.公司简介：Medpace 是一家成立超过30年的晚期合同研究组织，为中小型生物技术、制药和医疗器械公司提供全方位的药物开发和临床试验服务。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250422213111a4628958&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250422213111a4628958&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4121","MEDP","LU2065170008.USD","BK4585","LU2065171311.SGD","LU2065171402.SGD","LU2065169927.USD","BK4588"],"gpt_icon":0},{"id":"1147484446","title":"异动解读 | Medpace股价持续下跌，盘前再跌5.60%，投行下调目标价引发市场担忧","url":"https://stock-news.laohu8.com/highlight/detail?id=1147484446","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1147484446?lang=zh_cn&edition=full","pubTime":"2025-04-22 16:24","pubTimestamp":1745310264,"startTime":"0","endTime":"0","summary":"临床研究机构Medpace Holdings Inc.今日盘前股价继续大跌5.60%，延续了前一交易日的下跌趋势，引发市场广泛关注。造成Medpace股价持续下跌的主要原因是投资银行杰富瑞下调了公司的目标价。这一下调暗示Medpace的估值可能需要重新评估，引发了投资者对公司发展前景的质疑。值得注意的是，Medpace股价在前一交易日已经出现大幅下跌。今日盘前的持续下跌表明，投资者对杰富瑞的评级变化反应强烈，市场情绪仍然低迷。","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["MEDP"],"gpt_icon":0},{"id":"1103050424","title":"异动解读 | Medpace Holdings夜盘大跌8.30%，投行下调目标价","url":"https://stock-news.laohu8.com/highlight/detail?id=1103050424","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1103050424?lang=zh_cn&edition=full","pubTime":"2025-04-22 11:00","pubTimestamp":1745290847,"startTime":"0","endTime":"0","summary":"美国临床研究机构Medpace Holdings Inc.周一夜盘股价大跌8.30%，引发市场广泛关注。目标价的下调可能暗示Medpace的估值需要重新评估，这让投资者对公司的未来发展产生了疑虑。值得注意的是，Medpace在盘后交易中已经出现了6.15%的跌幅，夜盘的进一步下跌显示投资者对这一评级变化反应强烈。作为一家为生物技术、制药和医疗器械行业提供外包临床开发服务的领先企业，Medpace的股价波动也可能反映了市场对整个生物医药行业前景的担忧。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["MEDP"],"gpt_icon":0},{"id":"1127914345","title":"异动解读 | Medpace股价盘后大跌6.15%，投行下调目标价","url":"https://stock-news.laohu8.com/highlight/detail?id=1127914345","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1127914345?lang=zh_cn&edition=full","pubTime":"2025-04-22 04:36","pubTimestamp":1745267789,"startTime":"0","endTime":"0","summary":"Medpace Holdings Inc.周一盘后股价大跌6.15%，引发市场关注。消息面上，投资银行杰富瑞在周一将Medpace的目标价从300美元下调至285美元。杰富瑞的分析师认为，Medpace的估值可能需要重新评估，这反映了市场对该公司未来增长前景的担忧。Medpace是一家领先的临床研究机构，专门为生物技术、制药和医疗器械行业提供外包临床开发服务。目标价的下调可能反映了分析师对生物医药行业整体环境的谨慎态度，或是对Medpace公司特定业务挑战的担忧。","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"异动解读 | Medpace股价盘后大跌6.15%，投行下调目标价","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["MEDP"],"gpt_icon":0},{"id":"2529386358","title":"Medpace Hldgs(MEDP.US)：2025年Q1财报实现营收5.586亿美元，前值为5.11亿美元，预期值为5.271亿美元；每股收益为3.67美元，前值为3.20美元，预期值为3.08美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2529386358","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529386358?lang=zh_cn&edition=full","pubTime":"2025-04-22 04:21","pubTimestamp":1745266905,"startTime":"0","endTime":"0","summary":"Medpace Hldgs(MEDP.US)：2025年Q1财报实现营收5.586亿美元，前值为5.11亿美元，预期值为5.271亿美元；每股收益为3.67美元，前值为3.20美元，预期值为3.08美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/04/22042149732692.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["MEDP"],"gpt_icon":0},{"id":"2528784872","title":"Medpace Holdings, Inc.跌1.67% 股价跌破300美元大关","url":"https://stock-news.laohu8.com/highlight/detail?id=2528784872","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2528784872?lang=zh_cn&edition=full","pubTime":"2025-04-17 01:41","pubTimestamp":1744825260,"startTime":"0","endTime":"0","summary":"北京时间2025年04月17日01时41分，Medpace Holdings, Inc.股票出现异动，股价大幅下跌1.67%。Medpace Holdings, Inc.股票所在的生命科学行业中，整体跌幅为0.74%。Medpace Holdings, Inc.公司简介：Medpace 是一家成立超过30年的晚期合同研究组织，为中小型生物技术、制药和医疗器械公司提供全方位的药物开发和临床试验服务。全球私募股权公司Cinven于2014年以9.15亿美元收购了Medpace，并于2018年退出了投资。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250417014100a45b6667&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250417014100a45b6667&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4121","MEDP","LU2065170008.USD","BK4585","BK4588","LU2065169927.USD","LU2065171311.SGD","LU2065171402.SGD"],"gpt_icon":0},{"id":"2527116179","title":"TD Cowen：下调Medpace Hldgs(MEDP.US)评级，由买入调整至持有评级, 目标价由370.00美元调整至328.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2527116179","media":"金融界","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2527116179?lang=zh_cn&edition=full","pubTime":"2025-04-15 01:11","pubTimestamp":1744650696,"startTime":"0","endTime":"0","summary":"TD Cowen：下调Medpace Hldgs(MEDP.US)评级，由买入调整至持有评级, 目标价由370.00美元调整至328.00美元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/04/15011149535914.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["MEDP","TD"],"gpt_icon":0},{"id":"2527164248","title":"Medpace Holdings, Inc.涨0.77% 股价突破300美元大关","url":"https://stock-news.laohu8.com/highlight/detail?id=2527164248","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2527164248?lang=zh_cn&edition=full","pubTime":"2025-04-14 21:44","pubTimestamp":1744638258,"startTime":"0","endTime":"0","summary":"北京时间2025年04月14日21时44分，Medpace Holdings, Inc.股票出现波动，股价急速拉升0.77%。Medpace Holdings, Inc.股票所在的生命科学行业中，整体涨幅为1.21%。Medpace Holdings, Inc.公司简介：Medpace 是一家成立超过30年的晚期合同研究组织，为中小型生物技术、制药和医疗器械公司提供全方位的药物开发和临床试验服务。全球私募股权公司Cinven于2014年以9.15亿美元收购了Medpace，并于2018年退出了投资。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250414214418a458923c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250414214418a458923c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2065170008.USD","BK4585","LU2065171402.SGD","LU2065171311.SGD","LU2065169927.USD","BK4121","BK4588","MEDP"],"gpt_icon":0},{"id":"2526318611","title":"Medpace Holdings, Inc.盘中异动 下午盘股价大涨5.13%报296.81美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2526318611","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2526318611?lang=zh_cn&edition=full","pubTime":"2025-04-12 01:52","pubTimestamp":1744393939,"startTime":"0","endTime":"0","summary":"北京时间2025年04月12日01时52分，Medpace Holdings, Inc.股票出现异动，股价急速上涨5.13%。截至发稿，该股报296.81美元/股，成交量40.3311万股，换手率1.33%，振幅6.44%。Medpace Holdings, Inc.股票所在的生命科学行业中，整体涨幅为2.13%。Medpace Holdings, Inc.公司简介：Medpace 是一家成立超过30年的晚期合同研究组织，为中小型生物技术、制药和医疗器械公司提供全方位的药物开发和临床试验服务。全球私募股权公司Cinven于2014年以9.15亿美元收购了Medpace，并于2018年退出了投资。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025041201521994d31f48&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025041201521994d31f48&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4121","LU2065170008.USD","BK4588","LU2065169927.USD","LU2065171311.SGD","LU2065171402.SGD","MEDP","BK4585"],"gpt_icon":0},{"id":"2514063909","title":"盟科药业：全资子公司盟科美国对Medpace提起诉讼","url":"https://stock-news.laohu8.com/highlight/detail?id=2514063909","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514063909?lang=zh_cn&edition=full","pubTime":"2025-02-25 16:52","pubTimestamp":1740473555,"startTime":"0","endTime":"0","summary":"每经AI快讯，2月25日，盟科药业公告称，公司全资子公司盟科美国于2025年2月24日收到美国俄亥俄州南区联邦地区法院西部分院起诉立案确认通知，盟科美国诉Medpace合同纠纷一案已完成起诉立案。盟科美国请求判令Medpace赔偿因违反合同义务和不当行为导致的损失、成本和费用以及利息，具体金额将在庭审中证明。目前案件尚未开庭审理，最终实际影响需以后续法院判决或执行结果为准。公司已完成注射用MRX-4的中国III期临床试验，本次诉讼事宜不涉及对该试验的影响。文章来源：每日经济新闻原标题：盟科药业：全资子公司盟科美国对Medpace提起诉讼","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225170609a2532c26&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225170609a2532c26&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2065171311.SGD","LU2065170008.USD","BK4121","LU2065171402.SGD","BK4588","MEDP","LU2065169927.USD","BK4585"],"gpt_icon":0},{"id":"2511692167","title":"Medpace Holdings, Inc.2024财年实现净利润4.04亿美元，同比增加42.76%","url":"https://stock-news.laohu8.com/highlight/detail?id=2511692167","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511692167?lang=zh_cn&edition=full","pubTime":"2025-02-15 00:00","pubTimestamp":1739548835,"startTime":"0","endTime":"0","summary":"2月15日，Medpace Holdings, Inc.公布财报，公告显示公司2024财年净利润为4.04亿美元，同比增加42.76%；其中营业收入为21.09亿美元，同比增加11.82%，每股基本收益为13.06美元。从资产负债表来看，Medpace Holdings, Inc.总负债12.75亿美元，其中短期债务23.29百万美元，资产负债比为1.65，流动比率为0.94。机构评级：截至2025年2月15日，当前有8家机构对Medpace Holdings, Inc.目标价做出预测，其中目标均价为354.38美元，其中最低目标价为300.00美元，最高目标价为400.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250215000055a246151e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250215000055a246151e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MEDP"],"gpt_icon":0},{"id":"2510312861","title":"净利润飙升50%！CRO龙头Q4业绩公布","url":"https://stock-news.laohu8.com/highlight/detail?id=2510312861","media":"生物药大时代","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510312861?lang=zh_cn&edition=full","pubTime":"2025-02-12 11:53","pubTimestamp":1739332418,"startTime":"0","endTime":"0","summary":"近日，海外CRO龙头Medpace公布2024年业绩：截至 2024 年 12 月 31 日止，全年收入21.09亿美元，同比增长11.8% 。其中Q4营收5.366 亿美元，同比增长7.7%，积压订单转化率为 18.3%。值得注意的是，Q4净利润激增50％到1.17 亿美元；全年净利润大增43%至4.04亿美元。截至 2025 年 2 月 12 日，其总市值达 109.9 亿美元。自上市以来，该公司表现较为亮眼，上市 8 年间股价大涨超 1600%，并在 2024 年 7 月 17 日创下 459.77 美元的历史新高水平 。目前，全球约有一千多家 CRO 机构，大型企业占据主导地位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250212140209abcbd90e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250212140209abcbd90e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MEDP"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.medpace.com","stockEarnings":[{"period":"1week","weight":-0.0298},{"period":"1month","weight":-0.0216},{"period":"3month","weight":-0.164},{"period":"6month","weight":-0.184},{"period":"1year","weight":-0.2584},{"period":"ytd","weight":-0.109}],"compareEarnings":[{"period":"1week","weight":-0.0043},{"period":"1month","weight":0.0287},{"period":"3month","weight":-0.0606},{"period":"6month","weight":-0.0566},{"period":"1year","weight":0.0849},{"period":"ytd","weight":-0.0371}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Medpace Holdings, Inc.是一家特拉华州的公司，并于2014年2月18日注册成立。按收入计算，该公司是世界领先的临床合同研究组织之一，专注于为生物技术、制药和医疗器械行业提供科学驱动的外包临床开发服务。该公司的使命是加快安全有效的医疗疗法的全球发展。该公司以提供全方位服务的I-IV期临床开发服务和治疗专业知识为中心，通过严格的运营模式将自己与竞争对手区分开来。","yearOnYearQuotes":[{"month":1,"riseRate":0.555556,"avgChangeRate":0.002993},{"month":2,"riseRate":0.333333,"avgChangeRate":-0.014452},{"month":3,"riseRate":0.666667,"avgChangeRate":0.000692},{"month":4,"riseRate":0.666667,"avgChangeRate":0.005652},{"month":5,"riseRate":0.444444,"avgChangeRate":0.02069},{"month":6,"riseRate":1,"avgChangeRate":0.07563},{"month":7,"riseRate":0.625,"avgChangeRate":0.121468},{"month":8,"riseRate":0.625,"avgChangeRate":0.022801},{"month":9,"riseRate":0.555556,"avgChangeRate":-0.013974},{"month":10,"riseRate":0.444444,"avgChangeRate":0.048648},{"month":11,"riseRate":0.666667,"avgChangeRate":0.062863},{"month":12,"riseRate":0.777778,"avgChangeRate":0.033803}],"exchange":"NASDAQ","name":"Medpace Holdings Inc.","nameEN":"Medpace"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.33.4","shortVersion":"4.33.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Medpace Holdings Inc.(MEDP)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Medpace Holdings Inc.(MEDP)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Medpace Holdings Inc.,MEDP,Medpace Holdings Inc.股票,Medpace Holdings Inc.股票老虎,Medpace Holdings Inc.股票老虎国际,Medpace Holdings Inc.行情,Medpace Holdings Inc.股票行情,Medpace Holdings Inc.股价,Medpace Holdings Inc.股市,Medpace Holdings Inc.股票价格,Medpace Holdings Inc.股票交易,Medpace Holdings Inc.股票购买,Medpace Holdings Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Medpace Holdings Inc.(MEDP)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Medpace Holdings Inc.(MEDP)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}